Remove category agency-information
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

MDCG 2023-3 , Questions and Answers on Vigilance Terms and Concepts as Outlined in the Regulation (EU) 2017/745 on Medical Devices, provides additional information on key vigilance terms. The document will become effective 6 months after publication (10 September 2023). The written procedure for incident reporting was inadequate.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – September/October

SQA

This guidance will help applicants interpret how to implement Essential Principles of Medical Device Safety and Performance using information that was issued in March 2020. It will also facilitate cross-border circulation of these critical health therapies as well as cross-border cooperation between public health authorities.

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Oversight of AI Software Developed by Health Care Providers

Health Law Advisor

In the last couple of years, each Fall, FDA has been updating a list of machine learning applications in health care that the agency has cleared or otherwise approved. [1] FDA has been regulating machine learning algorithms used in a clinical context for decades. 1] As of last Fall, the list included 521 products dating back to 1995.

FDA 98
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

The products had been improperly regularized in ANVISA as cosmetics since they are indicated for injectable use, a form that is not authorized for this category of product. After receiving complaints, ANVSA performed joint inspections with local health surveillance agencies.

FDA 52